Marapharm Ventures Inc Share Price Canadian Securities Exchange
Equities
CA56575M1086
Healthcare Facilities & Services
Sales 2020 | 2.27 3.1 189.21 | Sales 2021 | 3.15 4.31 262.8 | Capitalization | 10.06M 13.75M 839M |
---|---|---|---|---|---|
Net income 2020 | -40M -54.69M -3.34B | Net income 2021 | -8M -10.94M -667M | EV / Sales 2020 | 1,35,92,488 x |
Net Debt 2020 | 5.3M 7.25M 442M | Net Debt 2021 | 13.31M 18.19M 1.11B | EV / Sales 2021 | 74,17,546 x |
P/E ratio 2020 |
-0.45
x | P/E ratio 2021 |
-1.08
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 71.26% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Searle
IRO | Public Communications Contact | - | - |
James O’Sullivan
SEC | Corporate Secretary | - | 18/20/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott R. Berman
BRD | Director/Board Member | - | - |
Dylan Rexing
BRD | Director/Board Member | - | 08/20/08 |
1st Jan change | Capi. | |
---|---|---|
+29.90% | 272M | |
+44.86% | 261M | |
+50.00% | 194M | |
+43.48% | 131M | |
-28.57% | 121M | |
+115.91% | 119M | |
-36.75% | 119M | |
0.00% | 86.82M | |
+150.00% | 75.33M |